TrialClinical lung cancer2018

Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.

Howard L West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.